U.S. federal trademark · Serial No. 88509950
Gene editing for developing cells and pharmaceuticals for medical and clinical use; gene editing for developing cells and pharmaceuticals for scientific and research use; research and development of therapeutics pharmaceuticals using gene editing; pharmaceutical, medical, scientific, and biopharmaceutical research and development; medical laboratory services; scientific laboratory services; custom cell-line engineering services; medical and scientific research in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; providing medical research and scientific research information in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; scientific research and development services relating to targeting therapies to individuals
Education services, namely, seminars and conferences, and providing online non-downloadable articles and newsletters, all in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.